• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LEICA BIOSYSTEMS MELBOURNE PTY. LTD. PELORIS RAPID TISSUE PROCESSOR; AUTOMATED TISSUE PROCESSOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LEICA BIOSYSTEMS MELBOURNE PTY. LTD. PELORIS RAPID TISSUE PROCESSOR; AUTOMATED TISSUE PROCESSOR Back to Search Results
Model Number PELORIS
Device Problem Appropriate Term/Code Not Available (3191)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 11/08/2016
Event Type  malfunction  
Manufacturer Narrative
A leica biosystems representative from north america technical support who contacted the complainant on 09 november 2016, was advised that no action was required from leica biosystems; and the offer of support/assistance was refused.Based on the information provided by the complainant that the sub-optimal tissue processing was resolved following replacement of the "70% alcohols", it is considered possible that the interaction between the device and the user either caused or contributed to the sub-optimal tissue processing reported.As a consequence of this possible use error involving completion of the reagent replacement process, it was determined that the available information meets the regulatory agency reportability criteria because the circumstance described has previously caused a serious injury.
 
Event Description
Leica biosystems received a complaint that prostate biopsy samples in six (6) cassettes, which had been processed in a protocol executed in retort b, which completed at 07:00 am, were "hard to cut." the complainant advised that a total of 82 cassettes had been processed in the affected protocol; and the tissue samples in the remaining 76 cassettes, which were gastro-intestinal biopsy samples, were not adversely affected.The complainant also advised that no complaint(s) had been received regarding the morphology of the affected samples; all specimens were diagnosable; no error(s) had been recorded during execution of the affected protocol and that: "70% alcohols were changed the problem was gone.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PELORIS RAPID TISSUE PROCESSOR
Type of Device
AUTOMATED TISSUE PROCESSOR
Manufacturer (Section D)
LEICA BIOSYSTEMS MELBOURNE PTY. LTD.
495 blackburn road
mount waverley, victoria 3149
AS  3149
Manufacturer (Section G)
LEICA BIOSYSTEMS MELBOURNE PTY. LTD.
495 blackburn road
mount waverley, victoria 3149
AS   3149
Manufacturer Contact
adrienne hardisty
495 blackburn road
mount waverley, victoria 3149
AS   3149
92117535
MDR Report Key6128285
MDR Text Key60942288
Report Number8020030-2016-00081
Device Sequence Number1
Product Code IEO
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 11/09/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/27/2016
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Model NumberPELORIS
Device Catalogue Number26.0005
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/09/2016
Was Device Evaluated by Manufacturer? No
Date Device Manufactured03/28/2007
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
-
-